{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:56:22Z","timestamp":1768031782286,"version":"3.49.0"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"17","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,11,1]]},"abstract":"<jats:p>This Medical News article discusses how abortion bans could affect patients for whom teratogenic drugs are the standard of care.<\/jats:p>","DOI":"10.1001\/jama.2022.11489","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T15:01:09Z","timestamp":1665586869000},"page":"1671","source":"Crossref","is-referenced-by-count":7,"title":["Threats to Evidence-Based Care With Teratogenic Medications in States With Abortion Restrictions"],"prefix":"10.1001","volume":"328","author":[{"given":"Rita","family":"Rubin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2797484\/jama_rubin_2022_mn_220060_1666287348.63473.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T15:10:52Z","timestamp":1667315452000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2797484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,1]]},"references-count":0,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2022,11,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.11489","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11,1]]}}}